Voyager Therapeutics Inc’s filing revealed that its Chief Legal Officer Fahey Sandell Jacquelyn unloaded Company’s shares for reported $34914.0 on Oct 02 ’24. In the deal valued at $5.82 per share,5,999 shares were sold. As a result of this transaction, Fahey Sandell Jacquelyn now holds 86,001 shares worth roughly $0.59 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Fahey Sandell Jacquelyn bought 5,999 shares, generating $34,920 in total proceeds.
Before that, Swartz Robin sold 1,357 shares. Voyager Therapeutics Inc shares valued at $13,407 were divested by the Chief Operating Officer at a price of $9.88 per share. As a result of the transaction, Swartz Robin now holds 117,004 shares, worth roughly $0.8 million.
A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in mid October with a ‘”an Outperform”‘ rating. Guggenheim began covering VYGR with “Buy” recommendation on March 26, 2024. H.C. Wainwright started covering the stock on March 19, 2024. It rated VYGR as “a Buy”.
Price Performance Review of VYGR
On Friday, Voyager Therapeutics Inc [NASDAQ:VYGR] saw its stock jump 18.69% to $6.86. Over the last five days, the stock has gained 26.34%. Voyager Therapeutics Inc shares have fallen nearly -18.72% since the year began. Nevertheless, the stocks have fallen -2.42% over the past one year. While a 52-week high of $11.72 was reached on 01/02/24, a 52-week low of $5.19 was recorded on 11/21/24. SMA at 50 days reached $6.52, while 200 days put it at $7.73.
Levels Of Support And Resistance For VYGR Stock
The 24-hour chart illustrates a support level at 6.41, which if violated will result in even more drops to 5.95. On the upside, there is a resistance level at 7.17. A further resistance level may holdings at 7.48. The Relative Strength Index (RSI) on the 14-day chart is 58.49, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.14, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 25.45%. Stochastics %K at 42.41% indicates the stock is a holding.
How much short interest is there in Voyager Therapeutics Inc?
A steep rise in short interest was recorded in Voyager Therapeutics Inc stocks on 2024-11-15, dropping by -1.0 million shares to a total of 2.44 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 3.45 million shares. There was a decline of -41.13%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on March 07, 2024 when Citigroup began covering the stock and recommended ‘”a Buy”‘ rating along with a $16 price target.
